Clinical Study
Impact of Pentoxifylline and Vitamin E on Ribavirin-Induced Haemolytic Anaemia in Chronic Hepatitis C Patients: An Egyptian Survey
Table 2
Comparison of patient profiles and laboratory data in both groups.
| Variable | Group 1 (vit E and pentoxifylline) n : 100 | Group 2 (control) n : 100 | value |
| Age (years) | | | NS | Sex M : F | 69 : 31 | 58 : 42 | NS | BMI kg/m2 | | | NS | Peripheral blood cell count | | | | Haemoglobin gm% | | | NS | Leukocyte (×103/mL) | | | NS | Platelet (×103/mL) | | | NS | Blood biochemistry | | | | AST (IU/L) | | | NS | ALT (IU/L) | | | NS | Bilirubin (mg/dL) | | | NS | Creatinine (mg/dL) | | | NS | A.P. (IU/L) | | | NS | Iron (mcg/dL) | | | NS | Ferritin ng/mL | | | NS | Liver Histology | | | | F1-F2 | 68 | 62 | NS | F3-F4 | 32 | 38 | HCV-RNA PCR viral load iu/mL | | | | <400,000 iu/mL | 66 | 58 | NS | >400,000 iu/mL | 34 | 42 | Ribavirin dosage | | | | 1000 mg/day | 38 | 29 | NS | 1200 mg/day | 62 | 71 |
|
|
NS: Non significant ().
|